Vidarsdottir, L., Fernandes, R. V., Zachariadis, V., Das, I., Edsbäcker, E., Sigvaldadottir, I., . . . Pokrovskaja Tamm, K. (2020). Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib. Melanoma Res.
استشهاد بنمط شيكاغوVidarsdottir, Linda, et al. "Silencing of CEBPB-AS1 Modulates CEBPB Expression and Resensitizes BRAF-inhibitor Resistant Melanoma Cells to Vemurafenib." Melanoma Res 2020.
MLA استشهادVidarsdottir, Linda, et al. "Silencing of CEBPB-AS1 Modulates CEBPB Expression and Resensitizes BRAF-inhibitor Resistant Melanoma Cells to Vemurafenib." Melanoma Res 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.